Fundraising Fox

Section 32

21 people tracked

Fox Verdict
Sign up to see your fit

Investment thesis

Section32 employs a high-conviction investment approach centered on deep founder partnerships and concentrated capital deployment. The firm targets a limited number of companies in artificial intelligence, computational biology, physical AI, infrastructure, cybersecurity, and enterprise sectors, leveraging its team's extensive experience across 500+ previous investments and 150+ exits. Rather than pursuing broad diversification, Section32 deliberately constrains its capital to prioritize meaningful engagement and long-term conviction over marginal opportunities.

Source: firm website, verified Jul 20, 2026.

Tracked investments
11

Team · 21 people

from the firm's website
Andrew Conrad, PhD· General Partner

Founder and former CEO of Verily, Alphabet's healthcare company, with three decades of experience building at the intersection of biology, data, and AI. Previously served as Chief Scientific Officer of LabCorp and co-founded the National Genetics Institute. Holds advanced degrees in neurobiology and cell biology from UCLA.

Andy Harrison· General Partner, CEO

CEO and General Partner of Section32 with executive experience at Alphabet's X and Verily, where he led business development and helped spin out SandboxAQ and Intrinsic. A two-time founder before Google, he is recognized for expertise in AI and regularly appears in major publications including The Wall Street Journal and Bloomberg.

Bill Maris· General Partner, Founder

Founder of Section32 and former CEO of Google Ventures, where he built a top-performing corporate venture fund and led Alphabet's private investing. He incubated Waymo, Verily, and Google X, and founded Calico. His track record includes 500+ investments, 30+ IPOs, and partnerships with founders at companies including Uber, Nest, Coinbase, and CrowdStrike.

Mike Pellini, MD· General Partner

Former CEO of Foundation Medicine, which transformed how oncologists and pharmaceutical companies evaluate cancer's genomic drivers before Roche's 2018 acquisition. Previously President and COO of Clarient, acquired by GE Healthcare. Brings three decades of expertise in personalized medicine and cancer research.

Alice Cheung· Partner, Talent

Leads talent strategy at Section32, advising portfolio companies and identifying top talent. Spent a decade at Alphabet as Google's top-producing recruiter and built original engineering teams for major projects including Waymo, Verily, and others. Completed over 1,700 hires throughout her career.

Bayan Alizadeh· Partner

Partner focused on enterprise software, AI, and deep tech investments. Previously an investor at Norwest Venture Partners leading investments in applied AI and infrastructure, and an investment banker at Morgan Stanley working on IPOs including Rivian and HashiCorp. Holds a B.S. from UC Berkeley.

Derrick Chow· Partner

Partner specializing in enterprise software, AI, and data infrastructure. Previously on the investment team at CapitalG working with companies including Stripe, UiPath, and Duolingo, and advised on capital raises and IPOs at Morgan Stanley. Graduated from UC Berkeley on a Gates Foundation scholarship.

Kenzo Fong· Partner, Product

Partner with 20+ years as a product and growth leader and two-time founder. Currently leads core AI product initiatives at Airtable. Built products at scale including Android ecosystem strategy, Google Maps marketing across EMEA, and founding Uber Eats from zero to $200M+ ARR.

Kimberly Shih· Partner, Talent

Talent Partner at Section32 driving talent strategy and building pipelines for portfolio companies. Started her career at a staffing firm specializing in engineering and design placements, then led hiring at Essential. Holds a B.S. from UC Santa Barbara and is SHRM-CP certified.

Wesley Tillu· Partner

Partner focused on technology investing with experience at In-Q-Tel leading investments across cybersecurity, AI/ML, and enterprise software. Previously scaled partnerships at Google Express and invested at Singapore's GIC. Holds an MBA from Wharton and degrees from Penn and Cornell.

Ayesha Arora· Venture Partner

Venture Partner focusing on enterprise software, AI, fintech, and cybersecurity investments. Previously worked at Brex on product marketing leading go-to-market campaigns, and completed co-ops at Airbnb and YouTube. Holds a B.S. in Business Administration and Communication Studies from Northeastern University.

Allison Pavlick· Investor Relations Principal

Investor Relations Principal at Section32 supporting fundraising and investor relations strategy. Previously held IR roles at 8VC and Blackstone, where she managed marketing strategy and supported private equity fundraising. Holds a B.S. in Finance from Penn State University.

Evalynne Dacayanan· Operations

Executive assistant and office lead at Section32's Palo Alto office supporting senior partners. Previously worked on operations teams at Google Ventures, Chronicle, Verily, and Redpoint Ventures, with over 15 years of support experience. Holds a B.A. in Political Science from UC Irvine.

Isabelle Ruddy· Accounting Manager

Accounting Manager at Section32 overseeing portfolio reporting, investor reporting, and tax functions. Previously on the finance team at Venrock and started her career in assurance at Ernst & Young serving biotech and semiconductor clients. Holds a B.S. in Accounting from Santa Clara University.

Jennie Chan· Controller

Controller at Section32 responsible for portfolio reporting, investor reporting, accounting, and tax functions. Previously worked in finance and accounting at Sequoia Capital and Sansome Partners. Began her career at PricewaterhouseCoopers specializing in venture capital and private equity tax matters.

Linda Boorman· Operations

Executive assistant supporting Andrew Conrad with four decades of corporate administration experience in groundbreaking environments including LabCorp and Google. Has supported high-profile figures across multiple industries. Holds a B.A. in Journalism and Sociology from Baylor University.

Nick Smith· Chief Investor Relations Officer

Chief Investor Relations Officer building and managing relationships with limited partners and prospective investors. Previously Head of Investor Relations at Foresite Capital and opened Winton Group's San Francisco office. Has experience in state government roles within the California Governor's office and State Controller's office.

Nina Labatt· Chief Financial Officer & Chief Operating Officer

Chief Financial Officer and Chief Operating Officer establishing world-class finance and operations systems at Section32. Previously served as COO and General Partner at Trinity Ventures. Industry expert in venture capital back office operations with 20+ years in the sector, and holds an MBA from Harvard Business School.

Olivia Lu· Assistant Controller

Assistant Controller at Section32 overseeing portfolio and investor reporting, accounting, and tax functions. Previously served as Portfolio Valuation Manager at KKR and began her career in tax at PricewaterhouseCoopers specializing in venture capital. Holds a B.S. from Shanghai Jiao Tong University and Master's in Accounting.

Robyn Villaro· Operations

Executive assistant at Section32. Previously worked as Office Administrator at Evidation and held administrative roles at the County of San Mateo and City and County of San Francisco. Holds a B.S. in Business Administration from San Francisco State University.

Tom Zhang· Head of Data

Head of Data at Section32 creating and growing data and analytics solutions supporting investment and operational decisions. Spent 13 years at Alphabet in ads analytics and economics teams, then served as Chief Data Scientist at Sinovation Ventures. Holds a B.A. in Mathematics from Peking University and Ph.D. in Statistics from Stanford University.

What they invest in

from 10 of 11 portfolio companies

AI & Machine Learning ×6Biotech ×4Digital Health ×4SaaS ×4Deep Tech ×3Healthtech ×3Medical Devices ×3Cybersecurity ×2

HQs:United States×6

Investments · 11 tracked

founders shown can be your intro path
Aspen Neuroscienceaspenneuroscience.com✓ verified

Aspen Neuroscience develops iPSC-derived autologous cell therapies for neurological diseases, with a lead product (ANPD001) in Phase 1/2a clinical trials for Parkinson's disease. The company is a clinical-stage biotechnology firm focused on personalized neuron replacement therapies.

BiotechDeep TechDigital HealthMedical Devices<UNKNOWN>, US

Andrés Bratt-Leal(Co-Founder and Senior Vice President, Research & Development)Damien McDevitt(President and Chief Executive Officer)

Formation Bioformation.bioin𝕏✓ verified

Formation Bio develops drugs through partnerships with health systems, academic medical centers, and research sites, focusing on clinical trials in dermatology, rheumatology, and cardiometabolic diseases. The company provides trial management infrastructure, monitoring, technology, and enrollment support to accelerate drug development.

AI & Machine LearningBiotechDeep TechDigital HealthHealthtech

Ben Liu(CEO & Co-Founder)Linhao Zhang(Co-Founder)

MedCryptmedcrypt.coin𝕏✓ verified

Medcrypt provides cybersecurity products and strategic consulting to medical device manufacturers to ensure devices are secure by design and meet regulatory requirements. The company combines technology solutions with management consulting and decision science to support the medical device industry.

CybersecurityHealthtechMedical DevicesSaaSSan Diego, US

Mike Kijewski(Founder)inEric Pancoast(Founder)in

Octaveoctavebio.com✓ verified

Octave develops blood-based biomarker tests for neurodegenerative diseases including multiple sclerosis, Parkinson's disease, and Alzheimer's disease. The company's tests enable physicians and patients to measure disease progression and treatment response through blood draws rather than traditional clinical assessments.

AI & Machine LearningBiotechDigital HealthMedical DevicesMenlo Park, US

William Hagstrom(Founder and Chairman)Doug Biehn(President and CEO)

BigHat Biosciencesbighatbio.comin𝕏

Big Hat Bio develops therapeutics under development across multiple programs. The company is a STEM-focused team working on therapeutic discovery and development.

AI & Machine LearningBiotechDeep TechSan Francisco, US

BloomAPIbloomtext.comin𝕏

BloomText provides HIPAA-compliant messaging software built specifically for healthcare organizations. The platform enables secure staff communication across Windows desktops and mobile devices with compliance features built in, requiring no separate configuration or compliance infrastructure.

Digital HealthHealthtechSaaSSeattle, US

Michael Wasser(Founder/CEO)inHeather Milone(Founder/Executive Business Advisor)in

Emaema.ai

EMA is an enterprise platform for building and scaling AI-powered workflows that automatically selects the best combination of models for each task to optimize accuracy, cost, and latency. The platform serves enterprise customers needing to deploy multiple AI workflows across their organization.

AI & Machine LearningEnterprise SoftwareSaaS

Inworld AIinworld.aiin𝕏

Inworld AI provides a full-duplex audio streaming platform that enables real-time conversational AI interactions with intelligent turn-taking, function calling, and multi-model routing capabilities for developers building conversational applications.

AI & Machine LearningDeveloper Tools

Limeli.me
Stairwellstairwell.com

Stairwell provides cybersecurity threat intelligence solutions to help teams identify and address security threats. The company serves organizations seeking to strengthen their cybersecurity posture and mission execution.

Cybersecurity

Wise Systemswisesystems.comin

Wise Systems provides an AI-driven routing optimization platform for delivery and fleet operations. The system helps dispatchers, drivers, and managers optimize last-mile deliveries to improve driver satisfaction and utilization.

AI & Machine LearningData & InfrastructureLogistics & Supply ChainSaaSCambridge, US

Dr. Sandy PentlandEdgar Blanco

Frequently asked questions

What sectors does Section 32 focus on?
Section 32 focuses on AI & Machine Learning, Biotech, Cybersecurity, Enterprise Software, Robotics.

Similar investors

Featured in lists